The Score Card Approach: A First Step Toward an Evidence-based Differentiation Assessment for Tablets.
BACKGROUND
The differentiation of tablets by their physical appearance is a contributing factor to the safe use of medications. In this study, a "score card" was developed to assess how well one tablet is differentiated from another tablet on the basis of the physical attributes of color, size, and shape.


METHODS
The score card was derived from a "2-out-of-5" difference test, in which participants were presented with groups of 5 tablets with varying color, size, and shape, and were asked to identify the 2 tablets that were different from the other 3 tablets.


RESULTS
Based on the study results (ie, recognition rate of the differences in the tablets, and confidence in such recognition), simplified metrics were derived to "score" a comparison of 2 tablets differing in color, size, and/or shape. The higher the score, the better the 2 tablets could be visually distinguished from each other. The scores were ranked as representing "strong," "moderate," or "weak" differentiation, with a corresponding stoplight color code, to create the final score card. The score card was internally verified by applying it to the tablets used in the study, then to the multiple strengths of Gilotrif® (afatinib) tablets, a Boehringer Ingelheim approved drug product.


CONCLUSION
The score card is a first step in the assessment of adequate differentiation of tablets and can be used for the design of tablets that promote safe use of medication.
['Pekari|Klaus|K|', 'Fürst|Thomas|T|', 'Gössl|Rüdiger|R|', 'Dudhedia|Mayur S|MS|', 'Segretario|James|J|', 'Sommer|Florian|F|', 'Watson|Patricia|P|']
drug product differentiation medication error physical differences risk assessment tool